The inverse correlation between SEZ6L2 expression and the prognosis of cancer patients was also demonstrated in lung cancer.12 Thus, the present study suggested that SEZ6L2 is a potential prognosis biomarker for CRC patients. This evidence concerns the gene SEZ6L2 and lung cancer.